株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腫瘍アブレーション治療の世界市場:分析、シェア、動向、規模、予測

Tumor Ablation Market, By Product (Cryoablation, Radiofrequency, and Microwave Ablation), By Treatment Type (Laparescopic, Surgical and Percutaneous), By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

発行 AnalystView Market Insights 商品コード 796161
出版日 ページ情報 英文 149 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.28円で換算しております。
Back to Top
腫瘍アブレーション治療の世界市場:分析、シェア、動向、規模、予測 Tumor Ablation Market, By Product (Cryoablation, Radiofrequency, and Microwave Ablation), By Treatment Type (Laparescopic, Surgical and Percutaneous), By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日: 2019年02月20日 ページ情報: 英文 149 Pages
概要

当レポートでは、世界の腫瘍アブレーション治療市場について調査分析し、市場概要、市場動向、産業分析、市場情勢、セグメント別の市場分析、主要ベンダー分析について、体系的な情報を提供しています。

第1章 腫瘍アブレーション治療:市場概要

  • 調査範囲
  • 前提条件と調査手法

第2章 エグゼクティブサマリー

第3章 腫瘍アブレーション治療:主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 腫瘍アブレーション治療:産業分析

  • ファイブフォース分析
  • 市場の魅力分析
  • 規制の枠組み分析

第5章 腫瘍アブレーション治療:市場情勢

  • 市場シェア分析

第6章 腫瘍アブレーション治療市場:製品別

  • 概要
  • 冷凍アブレーション
  • 高周波アブレーション
  • マイクロ波アブレーション

第7章 腫瘍アブレーション治療市場:適応別

  • 概要
  • 肝臓がん
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 骨転移
  • 耳鼻咽喉科がん

第8章 腫瘍アブレーション治療市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第9章 主要ベンダー分析

  • Galil Medical, Inc.
  • Misonix, Inc.
  • HealthTronics
  • Angiodynamics
  • Covidien plc
  • Boston Scientific Corporation
  • Medtronic Plc.
  • SonaCare Medical
  • EDAP TMS S.A.
  • Neuwave Medical, Inc.

第10章 アナリストの見解

第11章 付録

図表

List of Tables

  • Table 1: List of Acronyms
  • Table 2: Key Market Facts, 2014 - 2025
  • Table 3: Market Drivers: Impact Analysis
  • Table 4: Market Restraint: Impact Analysis
  • Table 5: Market Opportunity: Impact Analysis
  • Table 6: PEST Analysis
  • Table 7: Porter's Five Forces Analysis
  • Table 8: Company Market Share Analysis
  • Table 9: Global Tumor Ablation Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10: Tumor Ablation Market, by Product, 2014 - 2025 (USD Billion)
  • Table 11: Tumor Ablation Market, by Application, 2014 - 2025 (USD Billion)
  • Table 12: Tumor Ablation Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 13: North America Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 14: U.S. Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 15: Canada Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 16: Europe Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 17: France Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 18: Germany Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 19: Asia Pacific Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 20: China Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 21: India Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 22: Latin America Tumor Ablation Market, 2014 - 2025 (USD Billion)
  • Table 23: MEA Tumor Ablation Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1: Research Methodology
  • Figure 2: Research Process Flow Chart
  • Figure 3: Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4: Regulatory Framework Analysis
  • Figure 5: Tumor Ablation Market, by Product, 2014 - 2025 (USD Billion)
  • Figure 6: Tumor Ablation Market, by Application, 2014 - 2025 (USD Billion)
  • Figure 7: Tumor Ablation Market, by Geography, 2014 - 2025 (USD Billion)
目次

REPORT HIGHLIGHT

Tumor ablation market was valued at USD 897.1 million by 2017, growing with 10.9% CAGR during the forecast period, 2018-2025.

Tumor ablation is a minimally invasive procedure which is majorly used to treat tumors present in kidney, liver, bone, and lungs. In tumor ablation, tissues are cooled or heated to less than -40°C or more than 60°C using thermal energy. The success rate of complete small liver cancer through this process is more than 85%. This treatment is a good option for those patients who failed during radiotherapy or chemotherapy.

Market Dynamics

The growing number of cancer patients worldwide support industry growth significantly. As per the World Health Organization (WHO), cancer has taken the life of 9.6 million people in 2018. Tumor ablation is quite effective in cases when the abnormal cell is not bigger than 3cms. This technology doesn't have any side effect and the patient doesn't require hospitalization. No large incisions are involved in tumor ablation which results in less recovery time.

Excellent growth has been observed in the global market owing to the increasing awareness regarding the benefits of tumor ablation devices over surgical and other conventional techniques. Geriatric population, rise in cancer cases, economical treatment options are some of the other factors to fuel the demand for this technology across the globe. It is anticipated that the tumor ablation market size will reach worth USD 2.10 billion by 2025 with a CAGR of 10.9%.

Product Takeaway

The market is classified into four types namely cryoablation, radiofrequency, microwave and other ablation technologies. Currently, the radiofrequency market is on the rise because of its targeted treatment without causing any damage to surrounding healthy cells. This product segment is accounted for over 35% revenue share of the overall market. Whereas microwave ablation category is anticipated to rise during the study period because of the rise in private funding for the development of this technology coupled with growing adoption by healthcare professionals. In addition, this product segment is gradually picking up the pace owing to the emergence of robot-assisted technique. The global demand for microwave ablation is expected to rise with a CAGR of 15.3% between 2017-2025.

Application Takeaway

Based on application, the industry is bifurcated as liver, breast, lung, prostate, and other types. In terms of market size, liver cancer is accounted for the highest revenue share of the global market. According to the American Institute of Cancer Research (AICR), there were over 840,000 new cases of liver cancer in 2018. Such an increasing disease rate is directing patients' focus towards this new technique of ablation. On contrary, lung cancer is projected to grow with a strong growth rate in the coming years. The main reason for the growth of this application segment is the rising consumption of alcohol and cigarette.

Regional Takeaway

North America is dominating the tumor ablation market owing to the increasing demand for minimally invasive surgeries. In terms of revenue, North America contributed $360.8 billion in 2017 and it is anticipated that this growth will increase with a CAGR of 10.5% during the forecast period. Asia-Pacific is the rapidly growing region due to the increase in the count of cancer patients, and favorable government support.

Key Vendor Takeaway

Companies like Galil Medical, Misonix, HealthTronics, Covidien plc, Boston Scientific, Medtronic plc, SonaCare Medical, and Neuwave Medical are the key players in this sector. This market has come up with numerous opportunities for vendors and is characterized by the participation of both local and multinational vendors.

Many strategies like new product launch and technological advancements are adopted by these companies to retain their position in the current market. For example, BARRX Medical Inc. is acquired by Covidien plc and this acquisition resulted in goodwill generation for the company. Similarly, Galil Medical has come up with a new family of cryoablation needles namely IcePearl 2.1CX, IceFORCE 2.1 CX. These products launch will add value to the company's portfolio.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2014 & 2016
  • Base Year - 2017
  • Estimated Year - 2018
  • Projected Year - 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government Agencies
  • Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY PRODUCT

  • Cryoablation
  • Radiofrequency Ablation
  • Microwave Ablation

MARKET, BY APPLICATION

  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Bone Metastasis
  • ENT Cancer

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

TABLE OF CONTENTS

1. TUMOR ABLATION MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. TUMOR ABLATION KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. TUMOR ABLATION INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. TUMOR ABLATION MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. TUMOR ABLATION MARKET - BY PRODUCT

  • 6.1. Overview
  • 6.2. Cryoablation
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. Radiofrequency Ablation
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.4. Microwave Ablation
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. TUMOR ABLATION MARKET - BY APPLICATION

  • 7.1. Overview
  • 7.2. Liver Cancer
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Breast Cancer
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.4. Lung Cancer
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.5. Prostate Cancer
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.6. Bone Metastasis
    • 7.6.1. Overview
    • 7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.7. ENT Cancer
    • 7.7.1. Overview
    • 7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. TUMOR ABLATION MARKET- BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.3. U.S.
    • 8.2.3.1. Overview
    • 8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.4. Canada
    • 8.2.4.1. Overview
    • 8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.3. France
    • 8.3.3.1. Overview
    • 8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.4. Germany
    • 8.3.4.1. Overview
    • 8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.5. Rest of Europe
    • 8.3.5.1. Overview
    • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.3. China
    • 8.4.3.1. Overview
    • 8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.4. India
    • 8.4.4.1. Overview
    • 8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.5. Rest of APAC
    • 8.4.5.1. Overview
    • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.5. Rest of the World
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.3. Latin America
    • 8.5.3.1. Overview
    • 8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.4. Middle East and Africa
    • 8.5.4.1. Overview
    • 8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

9. KEY VENDOR ANALYSIS

  • 9.1. Galil Medical, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. SWOT Analysis
    • 9.1.3. Key Developments
  • 9.2. Misonix, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. SWOT Analysis
    • 9.2.3. Key Developments
  • 9.3. HealthTronics
    • 9.3.1. Company Overview
    • 9.3.2. SWOT Analysis
    • 9.3.3. Key Developments
  • 9.4. Angiodynamics
    • 9.4.1. Company Overview
    • 9.4.2. SWOT Analysis
    • 9.4.3. Key Developments
  • 9.5. Covidien plc
    • 9.5.1. Company Overview
    • 9.5.2. SWOT Analysis
    • 9.5.3. Key Developments
  • 9.6. Boston Scientific Corporation
    • 9.6.1. Company Overview
    • 9.6.2. SWOT Analysis
    • 9.6.3. Key Developments
  • 9.7. Medtronic Plc.
    • 9.7.1. Company Overview
    • 9.7.2. SWOT Analysis
    • 9.7.3. Key Developments
  • 9.8. SonaCare Medical
    • 9.8.1. Company Overview
    • 9.8.2. SWOT Analysis
    • 9.8.3. Key Developments
  • 9.9. EDAP TMS S.A.
    • 9.9.1. Company Overview
    • 9.9.2. SWOT Analysis
    • 9.9.3. Key Developments
  • 9.10. Neuwave Medical, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. SWOT Analysis
    • 9.10.3. Key Developments

Client can request additional company profiling as per specific requirements

10. 360 DEGREE ANALYSTVIEW

11. APPENDIX

  • 11.1. Research Methodology
  • 11.2. Abbreviations
  • 11.3. Disclaimer
  • 11.4. Contact Us
Back to Top